At a $10 billion valuation—and spinning out new ventures—Colossal names the bluebuck its sixth de-extinction target, extending its biotech platform into antelope conservation through a global BioVault effort.
Dallas-based Colossal Biosciences’ nonprofit arm has doubled its funding to $100 million and released its first Impact Report as it puts technology to work from Yellowstone to the Texas Gulf Coast—and beyond.
The funding will support groundbreaking research into artificial womb technologies with the goal of protecting endangered species and advancing wildlife conservation efforts, the foundation said.
Long's Austin-based Re:wild and Dallas-based Colossal Biosciences have announced a new partnership to accelerate global efforts "to save species on the brink of extinction, search for lost species, and restore key habitats for species recovery and rewilding."
“The dodo is the symbol of man-caused extinction,” Dallas-based Colossal Co-Founder and CEO Ben Lamm said last January. “It’s only fitting that Colossal works to reverse that.” The newly announced partnership with the MWF could help advance Colossal's efforts by restoring the dodo's natural habitat.
Save the Elephants will deploy a small fleet of drones equipped with high resolution and infrared cameras to capture elephant behavioral data, which will then be processed by Colossal’s machine learning core to develop algorithms that will label elephants and automatically identify individual and collective social behavior.
OK, it may not be as big—or as fire-breathing—as the dragons that swooped over Westeros on "Game of Thrones." But Australia's Victorian Grassland Earless Dragon is every bit as magical for simply hanging in there, decades after many thought it was extinct. Now Texas-based Colossal Biosciences is partnering to help preserve it—and sequence its genome.
With only two known living female northern white rhinos left, Colossal Biosciences and BioRescue have joined forces to fend off a looming extinction of the species. At the cutting edge of science, they're harnessing genetic technologies to rewrite the rhino's fate.
North Texas is a big place, with plenty to do, see, hear, and watch. We scour the internet every week to find events and activities for you. As always, things may change at any time, so be sure to check the official website or registration page for the latest details....
Electric mobility is about more than battery range now. As EVs become part of everyday life, people want the experience to feel simple and reassuring, whether they are finding a charger, checking their vehicle status, making a payment, or getting help when they need it....
North Texas is a big place with plenty of opportunities. Here’s a curated roundup of contests and competitions; accelerator and recognition programs; and resource and grant opportunities for North Texas innovators. ...
Plano-based Secretome Therapeutics, a biotech company advancing therapies derived from neonatal cardiac progenitor cells (nCPC), has announced the closing of $30 million in Series A financing from RA Capital Management, a multi-stage investment manager focused on public and private healthcare, life sciences, and planetary health companies....
North Texas is a big place, with plenty to do, see, hear, and watch. We scour the internet every week to find events and activities for you. As always, things may change at any time, so be sure to check the official website or registration page for the latest details....
Electric mobility is about more than battery range now. As EVs become part of everyday life, people want the experience to feel simple and reassuring, whether they are finding a charger, checking their vehicle status, making a payment, or getting help when they need it....
North Texas is a big place with plenty of opportunities. Here’s a curated roundup of contests and competitions; accelerator and recognition programs; and resource and grant opportunities for North Texas innovators. ...
Plano-based Secretome Therapeutics, a biotech company advancing therapies derived from neonatal cardiac progenitor cells (nCPC), has announced the closing of $30 million in Series A financing from RA Capital Management, a multi-stage investment manager focused on public and private healthcare, life sciences, and planetary health companies....